Trinity Biotech
TRIB
A$0.88
Share price
-0.77%
Change (1 day)
-76.23%
Change (1 year)
Categories
Market capitalization of Trinity Biotech (TRIB)
Market cap: A$16.38 Million
As of June 2025 Trinity Biotech has a market cap of A$16.38 Million. This makes Trinity Biotech the world's 10130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Trinity Biotech from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$16.38 M | -53.81% |
| 2024 | A$35.47 M | 47.47% |
| 2023 | A$24.05 M | -56.6% |
| 2022 | A$55.43 M | 34.47% |
| 2021 | A$41.22 M | -60.19% |
| 2020 | A$0.10 B | 235.7% |
| 2019 | A$30.85 M | -54.59% |
| 2018 | A$67.94 M | -50.3% |
| 2017 | A$0.13 B | -38.36% |
| 2016 | A$0.22 B | -42.65% |
| 2015 | A$0.38 B | -23.32% |
| 2014 | A$0.50 B | -23.02% |
| 2013 | A$0.65 B | 110.59% |
| 2012 | A$0.31 B | 47.56% |
| 2011 | A$0.21 B | 14.65% |
| 2010 | A$0.18 B | 95.54% |
| 2009 | A$94.05 M | 123.27% |
| 2008 | A$42.12 M | -71.33% |
| 2007 | A$0.14 B | -27.24% |
| 2006 | A$0.20 B | 19.25% |
| 2005 | A$0.16 B | 218.49% |
| 2004 | A$53.17 M | -38.22% |
| 2003 | A$86.06 M | 256.27% |
| 2002 | A$24.15 M | -18.31% |
| 2001 | A$29.57 M | -25.91% |
| 2000 | A$39.91 M | -47.52% |
| 1999 | A$76.05 M | 38.61% |
| 1998 | A$54.86 M | -18.2% |
| 1997 | A$67.06 M | 39.47% |
| 1996 | A$48.08 M |
End of Day market cap according to different sources
On Jun 19th, 2025 the market cap of Trinity Biotech was reported to be:
A$16.51 Million
A$16.51 Million
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 OraSure Technologies OSUR | A$0.34 B | 2,020.39% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | A$9.99 B | 60,892.17% | 🇺🇸 USA |
 Abbott Laboratories ABT | A$358.27 B | 2,186,254.16% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | A$25.87 M | 57.90% | 🇺🇸 USA |
 QuidelOrtho QDEL | A$2.93 B | 17,811.35% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | A$232.56 B | 1,419,135.21% | 🇺🇸 USA |
 Danaher DHR | A$217.62 B | 1,327,980.48% | 🇺🇸 USA |